l-carnitine liver cirrhosis Putative role of BCAA and treatments in cirrhotic liver. A Impact of l-Carnitine Supplementation on
Description
Inhibition of CPT1a as a Prognostic Marker Can Synergistically Enhance the Antileukemic Activity of ABT199
Ne lpd tl az ajnlott napi adagot
Supplementing with levocarnitine among hemodialysis patients may diminish incidence of intradialytic hypotension
doi: 10.1016/j.freeradbiomed.2016.04.001
, ,
